MEMORANDUM OPINION

ROBERT MARIANI, District Judge.

I. INTRODUCTION AND PROCEDURAL HISTORY

Presently before the Court is a Motion for In Camera Review (Doc. 124) filed by Plaintiffs, Elaine and Victor Swanger and their child, B.J.S. On June 30, 2014, in response to Plaintiffs' motion, the Court issued an Order requiring Defendant, Diversified Treatment Alternatives, Inc. ("DTA"), to produce the specific documents contained in the Philadelphia Diversified Treatment Claim File Privilege Log identified by Plaintiffs in their motion (see Doc. 124, Ex. B, C, D) for an in camera inspection by this Court and deferring a determination of Plaintiffs' motion until the Court received the requested documents. (Doc. 138).1 DTA promptly produced the documents at issue. As a result, the Court issued an Order confirming that the information outlined by DTA in the Privilege Log accurately reflected the contents of the records, but requesting supplemental briefs by the parties detailing whether any of the documents were subject to any confidentiality protections or privileges under federal or state statute or at common law, other than the psychotherapist-patient privilege provided under 42 PA. CONS. STAT. ANN § 5944, and how any, or all, of the documents were, or were not, relevant to Plaintiffs' claims. (Doc. 144).

Plaintiffs' motion for in camera review enumerated specific documents, or categories of documents, listed in the Philadelphia Diversified Treatment Claim File Privilege Log. Specifically, Plaintiffs requested the listed (1) Psychological Evaluations, Psychiatric Evaluations, Neuropsychological Assessments, and Psychological/Psychiatric Evaluations, arguing that "at the very least, these documents contain non-privileged portions as determined with respect to the October 25, 2010 Psychological Evaluation"; (2) Case Notes and Summaries, claiming that these documents "would largely contain information other than communications between Defendant Mattison and his psychiatrist, such as opinions, observations, or diagnosis, which is not protected by the [psychotherapist-patient] privilege"; and (3) an email from Erik Cummings to Karen Bloom, because "the document is not likely to contain communications between Defendant Mattison and his psychiatrist and therefore not protected by the privilege." (Doc. 125, at 4).

As we previously stated in the Court's Memorandum Opinion denying Plaintiffs' Motion for Reconsideration of our March 17, 2014 Order (Doc. 120), a psychotherapist may not invoke the federal psychotherapist-patient privilege on behalf of his or her patient. However, while DTA alone may not invoke this privilege on behalf of Mattison, absent a waiver by Mattison or a decision by this Court that one of more of the documents at issue, or portions of those documents, are not protected by the psychotherapist-patient privilege or any other applicable federal or state statute or at common law, DTA has a legal and ethical duty to deny the Swangers access to the requested documents listed within the Privilege Log. It is undisputed that Mattison never signed a written waiver releasing any treatment records or documents in DTA's possession to Plaintiffs. Therefore, the issues before this Court are what protections, if any, apply to the requested documents and whether Mattison can be deemed to have waived by implication those protections with respect to some, or all, of his treatment records. For the reasons that follow, we have determined that all of the documents requested by Plaintiffs are protected from disclosure by the psychotherapist-patient privilege and/or the Mental Health Procedures Act and that Mattison did not waive any privilege such as to compel DTA to provide Plaintiffs with any of the requested documents. Accordingly, we will deny Plaintiffs' motion for in camera review.

II. ANALYSIS

As a threshold issue, the Court is governed by Federal Rule of Evidence 501 which provides that:

FED. R. EVID. 501. Consequently, while federal law recognizes a psychotherapist-patient privilege, see Jaffee v. Redmond, 518 U.S. 1, 116 S.Ct. 1923, 135 L.Ed.2d 337 (1996), the extent and specific contours of this established privilege are dictated by Pennsylvania law, subject to the Supreme Court's delineation that the alleged privileged communications were made (1) confidentially, (2) between a licensed psychotherapist and her patient, and (3) in the course of diagnosis or treatment, id. at 15. In light of these requirements, the Supreme Court also expressly rejected the necessity of a balancing analysis of the evidentiary need for disclosure of the psychotherapist-patient communications against the patient's privacy interests. Id. at 7, 17.

A. Psychotherapist-Patient Privilege Under 42 PA. CONS. STAT. ANN. § 5944

In the Commonwealth of Pennsylvania, the psychotherapist-patient privilege statute provides that:

42 PA. CONS. STAT. ANN. § 5944.

While exceptions exist to the patient-psychotherapist privilege, "[t]he law in [Pennsylvania] makes clear that the privilege accorded confidential communications between the client and the psychotherapist must prevail under most circumstances." Com. v. Simmons, 719 A.2d 336, 341 (Pa. Super. Ct. 1998). Cf. Jaffee, 518 U.S. at 18 n.19 ("Although it would be premature to speculate about most future developments in the federal psychotherapist privilege, we do not doubt that there are situations in which the privilege must give way, for example, if a serious threat of harm to the patient or to others can be averted only by means of a disclosure by the therapist").2 Pennsylvania Courts therefore look at several factors in determining what information contained in the psychiatric reports is protected by the psychotherapist-patient privilege.

Simmons, 719 A.2d at 341. Plaintiffs rely on this well-established case law in Pennsylvania, and state that "the psychiatric-patient privilege is a testimonial privilege that does not protect opinions, observations or diagnoses", to assert that certain documents listed in the Philadelphia Diversified Treatment Claim File Privilege Log are not subject to the asserted privilege. (Doc. 125, at 2). This statement seemingly concedes that certain documents, or portions thereof, are privileged to the extent they contain confidential communications made, and information given, by Mattison to his psychotherapist(s) in the course of his treatment.

Of critical importance, the Psychological Evaluations, Psychiatric Evaluations, Neuropsychological Assessments, and Psychological/Psychiatric Evaluations, as well as the case notes and summaries produced by DTA were beyond any serious doubt completed in the course of diagnosis or treatment. And, while the case law indicates that the opinions, observations, diagnosis, and treatment alternatives outlined by the psychotherapists who interviewed and spoke with Mattison during his treatment at DTA may not be privileged under Section 5944, such documents, and the information contained therein, as well as all other documents Plaintiffs request be reviewed in camera by this Court, are nevertheless entirely protected from disclosure by a different privilege, specifically, the Mental Health Procedures Act, 50 P.S. § 7101, et seq.3

B. Protection Under The Mental Health Procedures Act

In Defendants DTA and Alvin Weaver's supplemental brief, Defendants argue that "even if this Court finds that the documents are not protected by the psychotherapist-patient privilege, they are still protected from disclosure under the [Mental Health Procedures Act]". (Doc. 145, at 12).

The Mental Health Procedures Act ("MHPA") "establishes rights and procedures for all involuntary treatment of mentally ill persons, whether inpatient or outpatient, and for all voluntary inpatient treatment of mentally ill persons." 50 P.S. § 7103. The MHPA provides broad protection for the confidentiality of records, specifically:

Plaintiffs briefly address § 7111, arguing that Mattison waived his privilege of confidentiality by (1) testifying "in detail about his treatment at DTA, his sexually inappropriate behavior not only with [Plaintiff] BJS but with prior special education students and children in and outside of school"; (2) not asserting "any privilege of confidentiality when he testified at his deposition or in his criminal hearing"; (3) not contesting "the Court's finding that he waived the psychotherapist-patient privilege by producing Anderson's [October 25, 2010] report"; (4) not asserting any privilege of confidentiality when the Manifestation Deterrnination Review . . . was read into the record during the deposition of DTA employee Shelly Diggan"; and (5) placing his own mental state at issue. (Doc. 147, at 8).

The Court has previously addressed several of Plaintiffs' arguments in prior Opinions and Orders, and need not do so again in detail. With respect to Anderson's report, the Court did not find, as Plaintiffs' repeatedly contend in each of their briefs submitted to this Court since March, 2014, that Mattison "waived the psychotherapist-patient privilege by producing Anderson's [October 25, 2010] report." Rather, the Court held that the "erroneous" disclosure of the October, 2010 Psychological Evaluation amounted to an admission of a failure to assert the psychologist/psychiatrist-patient privilege as to this document and that Mattison's prior deposition testimony addressed most, if not all, of the historical information found in the evaluation at issue. (Doc. 109). The Court specifically identified portions of the evaluation that addressed Mattison's treatment as to which the privilege had not been waived and stated that these portions remained privileged. Id. Our narrow finding renders Plaintiffs' argument that Defendants' failure to contest this ruling somehow indicates that Mattison generally waived his privilege completely unavailing.

Plaintiffs heavily rely on the Superior Court of Pennsylvania's decision in Sprague v. Walter, wherein the Court found that the admission into evidence of a defendant's confidential medical and psychiatric records in a libel action against the defendant and the newspaper that employed him was proper. Sprague v. Walter, 656 A.2d 890 (Pa. Super. Ct. 1995). However, such reliance is inapposite given the facts of the present case. Plaintiffs seemingly cite Sprague for two propositions: (1) Mattison's testimony, "in detail" at his deposition, is somehow similar to that of the defendant in Sprague, and constitutes a waiver of the confidential documents; and (2) by not asserting the privilege of confidentiality during his discovery deposition, he waived the privilege. (See Doc. 147, at 7-8).

In Sprague, the Court rejected Defendant's argument that he had only testified "as to basic general information about his treatment" and therefore not waived the privilege, finding that the defendant "testified at a discovery deposition related to the instant case, about the various medical/psychiatric treatments he had received from the age of ten through 1979 . . . [and] the record shows that [Defendant] testified at some length during his deposition about many of the details of his treatment, including dates of treatment, reasons for seeking it, physicians seen, and diagnoses made." Sprague, 656 A.2d at 911. With respect to Plaintiffs' first argument, the facts here are significantly different. Mattison's deposition testimony demonstrates that, while he did testify in some detail as to the incident with Plaintiff B.J.S., his discussion of what occurred at DTA, including his treatment and diagnosis, is minimal and superficial at best. As a result, Plaintiffs' second argument that Mattison's failure to assert the privilege of confidentiality amounts to a waiver of his privilege is meritless. While "[a] privilege of non-disclosure must be asserted during a discovery proceeding or it will be waived", Sprague, 656 A.2d at 911 (citing Com. v. Kauffman, 605 A.2d 1243 (Pa. Super. 1992)), Mattison was not presented with a situation which would have necessitated that he invoke the privilege. Mattison was never asked about the specifics of his treatment, activities, or diagnosis at DTA, such as to elicit testimony with respect to these topics and to put him on notice that there was a need to assert the privilege. See Black's Law Dictionary (9th ed. 2009)(An implied waiver is "evidenced by a party's decisive, unequivocal conduct reasonably inferring the intent to waive. An implied waiver may arise where a person has pursued such a course of conduct as to evidence an intention to waive a right, or where his conduct is inconsistent with any other intention than to waive it. Waiver may be inferred from conduct or acts putting one off his guard and leading him to believe that a right has been waived.")(lnternal citations omitted). With respect to Plaintiffs' argument that Mattison waived any privilege of confidentiality by not asserting it "when the Manifestation Determination Review . . . was read into the record during the deposition of DTA employee Shelly Diggan" (Doc. 147, at 8), the same analysis applies. A review of the Manifestation Determination reveals no details of Mattison's treatment, activities, programs, or diagnosis while at DTA, only broadly referencing the fact that he is under the care of DTA and Alvin Weaver, and had previously been in the DTA program and discharged because he had "met all of [DTA/MLC]'s requirements to exit the residential program." (See Doc. 147, Ex. 2). Such broad and brief assertions, read into the record during another person's deposition, are grossly insufficient to put Mattison on notice such that his failure to assert the privilege amounts to a waiver that privilege.

Plaintiffs' argument that Mattison's failure to assert "any privilege of confidentiality when he testified . . . in his criminal hearing" is equally unavailing and this general principal has been expressly rejected by Pennsylvania state courts. See Christy, 749 A.2d at 559-560 ("Here, [Defendant] has not executed a release and none of the statutory exceptions permit disclosure of his records. We see no basis in law or in logic for the proposition that a patient waives confidentiality to his or her mental health records simply because he or she admitted guilt in a juvenile proceeding.").

Plaintiffs' assertion that Mattison has put his mental state at issue because he "asserted the affirmative defense that he lacked the requisite `malice or reckless indifference to any federally protected right of Plaintiffs' and did not `otherwise meet the requirements of outrageousness, maliciousness, or recklessness needed to support an award of punitive damages'" as well as providing Anderson's October 25, 2010 evaluation as an expert report (Doc. 147, at 4-5) is tenuous at best. While Mattison does assert such an affirmative defense, on the state of the record thus far, we see no indication that Mattison's defense is an assertion of a mental defect or infirmity that exonerates him or mitigates his conduct.

Consequently, to the extent that the opinions, observations, diagnosis, and treatment notes stated in the Psychological Evaluations, Psychiatric Evaluations, Neuropsychological Assessments, Psychological/Psychiatric Evaluations, and Case Notes and Summaries are not privileged under the federal psychotherapist-patient privilege and 42 PA. CONS. STAT. ANN. § 5944, they are covered by the MHPA's broad protections, wherein the disclosure of any document "concerning persons in treatment," regardless of the contents of that document, is forbidden.6 In light of Hahnemann and its progeny, the Court will therefore not conduct an in camera inspection as we could have done so only having first determined that Mattison explicitly or impliedly waived his privilege such as to prevent him from invoking the protections of 42 PA. CONS. STAT. ANN. § 5944 and the MHPA.7

III. CONCLUSION

For the foregoing reasons, the Court will deny Plaintiffs' Motion for In Camera Review (Doc. 124), A separate Order follows.